Qiagen R&D spending 2012-2023
This statistic shows the development of the R&D spending of Dutch biotech company Qiagen from 2012 to 2023. In 2023, R&D spending of this company stood at some 199 million U.S. dollars, almost same as in the year before. Qiagen N.V. is headquartered in the Netherlands and in Germany, and is operating in many countries around the world. The company is specialized on sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research.